These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18032109)

  • 1. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.
    Moroni F
    Curr Opin Pharmacol; 2008 Feb; 8(1):96-103. PubMed ID: 18032109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of cell death by poly(ADP-ribose) polymerase-1.
    Koh DW; Dawson TM; Dawson VL
    Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
    Meli E; Pangallo M; Baronti R; Chiarugi A; Cozzi A; Pellegrini-Giampietro DE; Moroni F
    Toxicol Lett; 2003 Apr; 139(2-3):153-62. PubMed ID: 12628750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A
    Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
    Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
    Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation.
    Zhang Y; Zhang X; Park TS; Gidday JM
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):868-77. PubMed ID: 15729291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L; Szabó C
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment.
    Moroni F; Chiarugi A
    FEBS J; 2009 Jan; 276(1):36-45. PubMed ID: 19087198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W; Alano CC; Garnier P; Swanson RA
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
    Crome O; Doeppner TR; Schwarting S; Müller B; Bähr M; Weise J
    J Neurosci Res; 2007 Jun; 85(8):1734-43. PubMed ID: 17455321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3. Life or death decisions: the cast of poly(ADP-ribose)polymerase (PARP) as a therapeutic target for brain ischaemia.
    Pellicciari R; Camaioni E; Costantino G
    Prog Med Chem; 2004; 42():125-69. PubMed ID: 15003720
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
    Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion.
    van Wijk SJ; Hageman GJ
    Free Radic Biol Med; 2005 Jul; 39(1):81-90. PubMed ID: 15925280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD
    Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
    McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
    Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
    Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.